Skip to main content

Table 2 Failure patterns of IFI group and ENI group

From: Evaluation of the value of ENI in radiotherapy for cervical and upper thoracic esophageal cancer: a retrospective analysis

 

IFI (n = 99, 100%)

ENI (n = 70, 100%)

Failure

53 (53%)

41 (59%)

In field recurrence

32 (32%)

21 (30%)

Alone

27 (27%)

17 (24%)

+ out-PTVeni cervical nodes

1 (1%)

1 (1%)

+ out-PTVifi in-PTVeni nodes

4 (4%)

3 (4%)

Isolated out-PTVifi in-PTVeni nodes

3 (3%)

2 (3%)

Isolated out-PTVeni cervical nodes

0

0

Out-PTVeni mediastinal nodes

2 (2%)

2 (3%)

Alone

0

0

+ out-PTVifi in PTVeni nodes

0

1 (1%)

+ with other distal nodes

2 (2%)

1 (1%)

Distal organ metastasis

15 (15%)

14 (20%)

Alone

8 (8%)

7 (10%)

+ in field recurrence

6 (6%)

5 (7%)

+ out-PTVifi in-PTVeni nodes

1 (1%)

2 (3%)

Secondary esophageal tumor

1 (1%)

2 (3%)

Alone

1 (1%)

1 (1%)

+ out-PTVifi in-PTVeni nodes

0

1 (1%)